| 000 | 01728 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516045353.0 | ||
| 264 | 0 | _c20110927 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1534-6080 | ||
| 024 | 7 |
_a10.1097/TP.0b013e31822527ca _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOrtega, Francisco | |
| 245 | 0 | 0 |
_aGastrointestinal quality of life improvement of renal transplant recipients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium drugs or agents: mycophenolate mofetil and enteric-coated mycophenolate sodium. _h[electronic resource] |
| 260 |
_bTransplantation _cAug 2011 |
||
| 300 |
_a426-32 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aDiarrhea _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastrointestinal Tract _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney Transplantation _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycophenolic Acid _xadministration & dosage |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aTablets, Enteric-Coated |
| 700 | 1 | _aSánchez-Fructuoso, Ana | |
| 700 | 1 | _aCruzado, José María | |
| 700 | 1 | _aGómez-Alamillo, Juan Carlos | |
| 700 | 1 | _aAlarcón, Antonio | |
| 700 | 1 | _aPallardó, Lluís | |
| 700 | 1 | _aMorales, José María | |
| 700 | 1 | _aOliver, Juan | |
| 700 | 1 | _aGuinea, Guillermo | |
| 773 | 0 |
_tTransplantation _gvol. 92 _gno. 4 _gp. 426-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/TP.0b013e31822527ca _zAvailable from publisher's website |
| 999 |
_c21008209 _d21008209 |
||